Search - tctmd.com

Displaying 621 - 640 of 701

Sort: Relevancy | Date

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Daily News

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

February 19, 2015

News Daily News

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

L.A. McKeown

February 19, 2015

News Daily News

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

Yael L. Maxwell

February 02, 2015

News Daily News

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

January 28, 2015

News Daily News

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

December 04, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

Presentation TCT 2014

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Albert Hsiao

September 15, 2014

Presentation TCT 2014

Heart Failure Before and After TAVR

Presenter: Howard C. Herrmann, Spencer H. Kubo, Stefan Sack

September 15, 2014

Presentation TCT 2014

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

Presenter: Blase A. Carabello, George D. Dangas

September 15, 2014

Presentation TCT 2014

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

Presenter: Blase A. Carabello, George D. Dangas, Lutz Buellesfeld

September 15, 2014

Presentation TCT 2014

TAVR Update: FDA-Approved Valve Systems

Presenter: Blase A. Carabello, George D. Dangas, Alan C. Yeung

September 15, 2014

Presentation TCT 2014

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Presenter: Blase A. Carabello, George D. Dangas, Patrick T. O'Gara

September 15, 2014

Presentation TCT 2014

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Zoltan G. Turi, Jason Kovacic

September 14, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

Advertisement

Study Finds Exponential Growth in Percutaneous LVAD Use

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Valvuloplasty Improves Short-term Outlook for Patients With Medically Managed Aortic Stenosis

TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Heart Failure Before and After TAVR

Controversies in Aortic Valve Disease: Challenging Clinical Scenarios (Asymptomatic AS, Low-Flow Low-Gradient AS, and Concomitant CAD)

TAVR On the Horizon: Emerging TAVR Platforms and Technologies

TAVR Update: FDA-Approved Valve Systems

Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content